BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24901713)

  • 1. Sinomenine sensitizes multidrug-resistant colon cancer cells (Caco-2) to doxorubicin by downregulation of MDR-1 expression.
    Liu Z; Duan ZJ; Chang JY; Zhang ZF; Chu R; Li YL; Dai KH; Mo GQ; Chang QY
    PLoS One; 2014; 9(6):e98560. PubMed ID: 24901713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line.
    Zrieki A; Farinotti R; Buyse M
    Pharm Res; 2008 Sep; 25(9):1991-2001. PubMed ID: 18581209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway.
    Chen T; Wang C; Liu Q; Meng Q; Sun H; Huo X; Sun P; Peng J; Liu Z; Yang X; Liu K
    Cancer Biol Ther; 2015; 16(1):106-14. PubMed ID: 25482933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line.
    Pagliarulo V; Ancona P; Niso M; Colabufo NA; Contino M; Cormio L; Azzariti A; Pagliarulo A
    Mol Cancer; 2013 May; 12():47. PubMed ID: 23705854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
    David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
    Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survivin transcription is associated with P-glycoprotein/MDR1 overexpression in the multidrug resistance of MCF-7 breast cancer cells.
    Liu F; Liu S; He S; Xie Z; Zu X; Jiang Y
    Oncol Rep; 2010 May; 23(5):1469-75. PubMed ID: 20372866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of COX-2 in colon cancer modulates tumor growth and MDR-1 expression to enhance tumor regression in therapy-refractory cancers in vivo.
    Rahman M; Selvarajan K; Hasan MR; Chan AP; Jin C; Kim J; Chan SK; Le ND; Kim YB; Tai IT
    Neoplasia; 2012 Jul; 14(7):624-33. PubMed ID: 22904679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
    J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.
    Zatelli MC; Luchin A; Tagliati F; Leoni S; Piccin D; Bondanelli M; Rossi R; degli Uberti EC
    Endocr Relat Cancer; 2007 Dec; 14(4):1029-38. PubMed ID: 18045954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
    Stein U; Walther W; Shoemaker RH
    J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Cα protects against multidrug resistance in human colon cancer cells.
    Lee SK; Shehzad A; Jung JC; Sonn JK; Lee JT; Park JW; Lee YS
    Mol Cells; 2012 Jul; 34(1):61-9. PubMed ID: 22639047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity.
    Yu L; Wu WK; Li ZJ; Liu QC; Li HT; Wu YC; Cho CH
    Mol Pharmacol; 2009 Jun; 75(6):1364-73. PubMed ID: 19264847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of multidrug-resistance cell line C(6)/adr and reversal of drug-resistance.
    Liu F; Wang C; Zhang Q; Li J; Zhang Y
    Chin Med J (Engl); 2002 Feb; 115(2):238-41. PubMed ID: 11940340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib.
    Chen C; Shen HL; Yang J; Chen QY; Xu WL
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):9-17. PubMed ID: 20229271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-495 sensitizes MDR cancer cells to the combination of doxorubicin and taxol by inhibiting MDR1 expression.
    Zou Z; Zou R; Zong D; Shi Y; Chen J; Huang J; Zhu J; Chen L; Bao X; Liu Y; Liu W; Huang W; Hu J; Chen Z; Lao X; Chen C; Huang X; Lu Y; Ni X; Fang D; Wu D; Lu S; Jiang M; Qiu C; Wu Y; Qiu Q; Dong Y; Su Y; Zhao C; Zhong Z; Cai J; Liang Y
    J Cell Mol Med; 2017 Sep; 21(9):1929-1943. PubMed ID: 28411377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glabridin resensitizes p-glycoprotein-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.
    Qian J; Xia M; Liu W; Li L; Yang J; Mei Y; Meng Q; Xie Y
    Eur J Pharmacol; 2019 Jun; 852():231-243. PubMed ID: 30959046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by small interfering RNA (siRNA) in doxorubicin-resistant MCF-7 breast cancer cells.
    Dönmez Y; Gündüz U
    Biomed Pharmacother; 2011 Mar; 65(2):85-9. PubMed ID: 21237614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.
    Kim HG; Hien TT; Han EH; Hwang YP; Choi JH; Kang KW; Kwon KI; Kim BH; Kim SK; Song GY; Jeong TC; Jeong HG
    Br J Pharmacol; 2011 Mar; 162(5):1096-108. PubMed ID: 21054339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-κB in R-HepG2 cell line.
    Sun J; Yeung CA; Co NN; Tsang TY; Yau E; Luo K; Wu P; Wa JC; Fung KP; Kwok TT; Liu F
    PLoS One; 2012; 7(8):e40720. PubMed ID: 22927901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.